Skip to main content

Steinhart Richard I

In the past year, 1 open-market sale filing worth $7.46K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$7.46K
1 filing
Net
−$7.46K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Steinhart Richard I as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BTAIQ BioXcel Therapeutics, Inc.

Chief Financial Officer8 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 22, 2026 (view filing)May 202 daysSteinhart Richard IChief Financial OfficerSSale−6.84K$1.09−$7.46K−20.7%26.3K after10b5-1
Dec 17, 2024 (view filing)6:06 PM ETDec 161 daySteinhart Richard IChief Financial OfficerSSale−577$0.3587−$206.98−2.7%20.9K after2 lots10b5-1
Oct 3, 2024 (view filing)Oct 3Same daySteinhart Richard IChief Financial OfficerSSale−7.17K$0.55−$3.95K−26.1%20.3K after10b5-1
Sep 17, 2024 (view filing)Sep 161 daySteinhart Richard IChief Financial OfficerSSale−356$0.69−$245.64−5.4%6.20K after10b5-1
Jun 18, 2024 (view filing)Jun 171 daySteinhart Richard IChief Financial OfficerSSale−372$1.26−$468.72−6.4%5.48K after10b5-1
Apr 8, 2024 (view filing)Apr 44 daysSteinhart Richard IChief Financial OfficerSSale−1.07K$2.64−$2.82K−18.3%4.76K after10b5-1
May 16, 2023 (view filing)May 151 daySteinhart Richard IChief Financial OfficerSSale−5.00K$27.17−$135.8K−76.9%1.50K after10b5-1
Mar 16, 2023 (view filing)Mar 151 daySteinhart Richard IChief Financial OfficerSSale−2.08K$19.50−$40.6K−58.1%1.50K after